Context drops bispecific T-cell engager on cost-cutting initiative

CT-95CTIM-76CT-202Negative

AI Analysis

Summary

Context discontinued CT-95, a bispecific T-cell engager, as part of a cost-cutting initiative. The company will focus resources on two other BiTE programs: CTIM-76 and CT-202.

Outcome Details

Program discontinuation as part of cost-cutting initiative

Importance:4/10

Sentiment:

-0.60

pipeline_reductioncost_cuttingbispecific_t_cell_engagerBiTE

Related Companies

$CNTX

Read the original article

Published by Clinical Trials Arena on August 7, 2026 10:05 AM

Read Original